oleandomycin

(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-6-hydroxy-5,7,8,11,13,15-hexamethyl-4,10-dioxo-14-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyloxy]-1,9-dioxaspiro[2.13]hexadec-12-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside

RZPAKFUAFGMUPI-QESOVKLGSA-N CHEBI:16869 0 Reactome links 4 studies
4 Observed studies
5 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
RZPAKFUAFGMUPI-QESOVKLGSA-N
IUPAC name
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-6-hydroxy-5,7,8,11,13,15-hexamethyl-4,10-dioxo-14-[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyloxy]-1,9-dioxaspiro[2.13]hexadec-12-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside
Preferred name
oleandomycin
INN name
Synonym
Amimycin
ChEBI
CHEBI:16869

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles